This panel seeks to get to the bottom of the IFR and what it means for the hemp CBD industry currently and in the future. We may also touch on the intersection of USDA and FDA authority to regulate hemp-derived CBD products.
Evolving cannabis product risks have the potential to result in enormous future liability for which cannabis and hemp companies are currently unprepared. This session will clarify those risks and discuss how embracing a mix of legal reform, policy changes and adoption of traditional risk management principles may prevent future product risk issues from damaging market sustainability.
In this session the panelist will set the stage by discussing the Agricultural Improvement Act, more commonly known as the Farm Bill; specifically, the watershed moment in 2018 where industrial hemp was provided a federally legal pathway. The panel will discuss the unintended consequences created by the definition and function of weight allowance for delta-9 THC and its application to manufactured hemp derived products. The impacts of the definition on the hemp industry, the regulated marijuana industry and overall public health.
Given the rapid developments that have taken place in just a short year, clients looking to enter the New York cannabis market will likely have many questions. Prepare yourself for these inevitable conversations now by signing up for our webinar where our legal experts will: (i) offer a general overview of the MRTA and adult-use licensing; (ii) break down recently-created adult-use conditional license types, the applicable eligibility criteria, and the potential impact of these conditional licenses on the State’s broader social and economic equity program; and (iii) explain how the State’s medical regulations will change if the proposed changes are adopted and what that means for the existing medical market, the adult-use market, and beyond. If you’re looking for a lively and informative discussion about all things cannabis in the Empire State, look no further – we’ve got you covered!
While jurisdictions such as Canada have given us a glimpse into some of the legal issues faced by a country choosing to legalize federally, other models have since emerged. What are these new jurisdictions? What do they have in common? What legal issues are they facing? Join us for a showcase of other countries who have recently “emerged” to join the global adult use, therapeutic, and industrial hemp markets.